Vectus Biosystems: Could this drug eventually prevent thousands of deaths? copertina

Vectus Biosystems: Could this drug eventually prevent thousands of deaths?

Vectus Biosystems: Could this drug eventually prevent thousands of deaths?

Ascolta gratuitamente

Vedi i dettagli del titolo

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

Vectus Biosystems: Could this drug eventually prevent thousands of deaths?

Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.

See omnystudio.com/listener for privacy information.

Ancora nessuna recensione